Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.

Clinical trial NCT00316680 · TERMINATED

Trial details

NCT number: NCT00316680
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Diphtheria Tetanus Hepatitis B Whole Cell Pertussis

Start date: 2006-03-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.